Loading...
XLON
4BB
Market cap99mUSD
Aug 28, Last price  
475.00GBP
Name

4Basebio PLC

Chart & performance

D1W1MN
XLON:4BB chart
P/E
P/S
43.45
EPS
Div yield, %
Shrs. gr., 5y
4.71%
Rev. gr., 5y
29.66%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
IPO date
Feb 17, 2021
Employees
61
Domiciled in
GB
Incorporated in
GB

Valuation

No data to show